Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00833560 · BASELINE

Baseline characteristics

A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy · Source last updated 2014-11-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      395
    units
    Participants
groups
  1. description
    Cyclophosphamide + Bortezomib + Dexamethasone for three 21-day cycles
    id
    BG000
    title
    Cyclophosphamide + Bortezomib + Dexamethasone
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          6.5
          value
          52.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Between 20 and 39 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          109
      title
      Between 40 and 49 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          253
      title
      Between 50 and 60 years
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          16
      title
      >65 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          166
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          229
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      395
    units
    Participants
groups
  1. description
    Cyclophosphamide + Bortezomib + Dexamethasone for three 21-day cycles
    id
    BG000
    title
    Cyclophosphamide + Bortezomib + Dexamethasone
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          6.5
          value
          52.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Between 20 and 39 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          109
      title
      Between 40 and 49 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          253
      title
      Between 50 and 60 years
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          16
      title
      >65 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          166
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          229
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice